Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK-JNK-mediated AKT/mTOR signaling pathway

Epidemiology and evidence have demonstrated that colon carcinoma is one of the most common gastrointestinal tumors in the clinic. Reports have suggested that Tunicamycin significantly inhibits aggressiveness of colon carcinoma cells by promotion of apoptosis. In the present study, the inhibitory eff...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Shuping, Li, Weihong, Guan, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802191/
https://www.ncbi.nlm.nih.gov/pubmed/29344654
http://dx.doi.org/10.3892/mmr.2018.8444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802191/
https://www.ncbi.nlm.nih.gov/pubmed/29344654
http://dx.doi.org/10.3892/mmr.2018.8444

Ejemplares similares